Journal article

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Dyer, M., Hale, G., Hayhoe, F., & Waldmann, H. (1988). EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY. BRITISH JOURNAL OF HAEMATOLOGY, 69(1), 119–119.

MLA Style

Dyer, M, et al. “EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY.” BRITISH JOURNAL OF HAEMATOLOGY, vol. 69, no. 1, 1988, pp. 119–19.

Chicago Style

Dyer, M, G Hale, F Hayhoe, and H Waldmann. 1988. “EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY.” BRITISH JOURNAL OF HAEMATOLOGY 69 (1): 119–19.
Print

Authors

+ Dyer, M More by this author

Role:: Author

+ Hale, G More by this author

Role:: Author

+ Hayhoe, F More by this author

Role:: Author

+ Waldmann, H More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Pathology Dunn School
Role:: Author

Journal:: BRITISH JOURNAL OF HAEMATOLOGY More from this journal
Volume:: 69
Issue:: 1
Pages:: 119-119
Publication date:: 1988-05-01
ISSN:: 0007-1048

Pubs id:: pubs:20756
UUID:: uuid:0edd553e-794d-4ebc-ba7b-2a13e2593451
Local pid:: pubs:20756
Source identifiers:: 20756
Deposit date:: 2012-12-19
ARK identifier:: ark:/29072/ora_0edd553e794d4ebcba7b2a13e2593451

Terms of use

Copyright date:: 1988

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP